-
Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials
Friday, March 22, 2024 - 3:40pm | 590On March 20, Congressional leaders at both the House and Senate Appropriations Committees released new spending legislation that would continue blocking Washington D.C.'s legal marijuana sales and fund psychedelic clinical studies. The new Financial Services and General Government legislation...